
Liebigs Annalen p. 41 - 47 (1997)
Update date:2022-08-05
Topics:
Ogrel, Alexei
Bloemhoff, Wim
Lugtenburg, Johan
Raap, Jan
The isotopically labelled C-terminal fragment of zervamicin, H-Hyp10-[4,4-2H2-Gln]-Aib-Hyp-Aib-Pro-Phl 16, has been synthesized in solution by a Fmoc/tert-butyl strategy in 28% overall yield. The Fmoc group was removed by reaction for 2 min with 0.1 M NaOH in dioxane/methanol/water, (30:9:1, v:v:v). The couplings of the sterically hindered Aib residues were achieved by means of either BOP/DMAP activation or Fmoc-Aib-Cl. Acid deprotection of the peptide was performed by reaction with 50% TFA in CH2Cl2 for 30 min without significant cleavage of the acid-labile Aib-Pro and Aib-Hyp peptide bonds. VCH Verlagsgcsellschaft mbH, 1997.
View MoreShanghai WinTide BioTechnology Co.,Ltd
Contact:86-21-37100630
Address:No. 908 Yunhe Road, Fengxian district, Shanghai
Lianyungang Ningkang Chemical Co., Ltd
Contact:.+86-518-88588008
Address:http://www.chemnk.com
Chengda Pharmaceuticals Co., Ltd.
Contact:+86-573-84601188
Address:hengshan Road 5# in Jiashan, zhejiang
Chemtrade International ( China )
Contact:+86-532-86893005
Address:Rm 2-501, Huaxia Zonghe Building, No. 410 JInggangshan Road, Huangdao
Hangzhou Hysen Pharma co.,Ltd.
website:http://www.hysenpharma.cn/
Contact:0086-571-88298791
Address:#701,Gudun Road Hangzhou
Doi:10.1002/chem.200400358
(2004)Doi:10.1021/ja01099a047
(1953)Doi:10.1016/S0040-4020(01)99384-6
(1973)Doi:10.1002/1521-3773(20010105)40:1<207::AID-ANIE207>3.0.CO;2-K
(2001)Doi:10.1002/adsc.201900949
(2019)Doi:10.1021/jo00241a032
(1988)